World Health Organization (WHO: Coronavirus Disease (COVID-19) Pandemic. WHO, Genova, 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=Cj0KCQiAhs79BRD0ARIsAC6XpaXhxHeN64r7-j5rvv0ZDtNGxNkA0e2 EWCAUr8QWWj-qi_PPrXOljroaAjXBEALw_wcB. Accessed 30, January 2023.

Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, Bonanomi E, Cabrini L, Carlesso E, Castelli G, et al: Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 180:1345–1355. 2020.PubMed/NCBI View Article : Google Scholar

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 395:1054–1062. 2020.PubMed/NCBI View Article : Google Scholar

Henry BM, de Oliveira MHS, Benoit S, Plebani M and Lippi G: Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 58:1021–1028. 2020.PubMed/NCBI View Article : Google Scholar

Skevaki C, Fragkou PC, Cheng C, Xie M and Renz H: Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect. 81:205–212. 2020.PubMed/NCBI View Article : Google Scholar

Bell R, Zini G, d'Onofrio G, Rogers HJ, Lee YS and Frater JL: The hematology laboratory's response to the COVID-19 pandemic: A scoping review. Int J Lab Hematol. 43:148–159. 2021.PubMed/NCBI View Article : Google Scholar

Ciaccio M and Agnello L: Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis (Berl). 7:365–372. 2020.PubMed/NCBI View Article : Google Scholar

Lippi G and Plebani M: The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 58:1063–1069. 2020.PubMed/NCBI View Article : Google Scholar

Lippi G and Plebani M: Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 58:1131–1134. 2020.PubMed/NCBI View Article : Google Scholar

Lim AYH, Goh JL, Chua MCW, Heng BH, Abisheganaden JA and George PP: Temporal changes of haematological and radiological findings of the COVID-19 infection-a review of literature. BMC Pulm Med. 21(37)2021.PubMed/NCBI View Article : Google Scholar

Parente J: Diagnostics for White Blood Cell Abnormalities. Physician Assistant Clinics. 4:625–635. 2019.

Yamada T, Wakabayashi M, Yamaji T, Chopra N, Mikami T, Miyashita H and Miyashita S: Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Clin Chim Acta. 509:235–243. 2020.PubMed/NCBI View Article : Google Scholar

Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, Hussein MH, Killackey MT, Fawzy MS and Kandil E: Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 15(e0238160)2020.PubMed/NCBI View Article : Google Scholar

Zhao X, Zhou L, Kou Y and Kou J: Activated neutrophils in the initiation and progression of COVID-19: Hyperinflammation and immunothrombosis in COVID-19. Am J Transl Res. 14:1454–1468. 2022.PubMed/NCBI

Banno A, Hifumi T, Okamoto H, Masaki M, Seki K, Isokawa S, Otani N, Hayashi K and Ishimatsu S: Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: A single-center observational study from the first wave. BMC Infect Dis. 21(163)2021.PubMed/NCBI View Article : Google Scholar

Aladağ N and Atabey RD: The role of concomitant cardiovascular diseases and cardiac biomarkers for predicting mortality in critical COVID-19 patients. Acta Cardiologica. 76:132–139. 2021.PubMed/NCBI View Article : Google Scholar

Zheng Y, Sun LJ, Xu M, Pan J, Zhang YT, Fang XL, Fang Q and Cai HL: Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China. J Zhejiang Univ Sci B. 21:378–387. 2020.PubMed/NCBI View Article : Google Scholar

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar

Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, Xie J, Guan W, Liang W, Ni Z, et al: Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 146:89–100. 2020.PubMed/NCBI View Article : Google Scholar

Wendel-Garcia PD, Fumeaux T, Guerci P, Heuberger DM, Montomoli J, Roche-Campo F, Schuepbacha RT and Hiltyet MP: RISC-19-ICU Investigators. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine. 25(100449)2020.PubMed/NCBI View Article : Google Scholar

Zanella A, Florio G, Antonelli M, Bellani G, Berselli A, Bove T, Cabrini L, Carlesso E, Castelli GP, Cecconi M, et al: Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units. Intensive Care Med. 47:995–1008. 2021.PubMed/NCBI View Article : Google Scholar

Chen A, Zhao Z, Hou W, Singer AJ, Li H and Duong TQ: Time-to-death longitudinal characterization of clinical variables and longitudinal prediction of mortality in COVID-19 patients: A two-center study. Front Med (Lausanne). 8(661940)2021.PubMed/NCBI View Article : Google Scholar

Xie J, Wu W, Li S, Hu Y, Hu M, Li J, Yang Y, Huang T, Zhenget K, Wang Y, et al: Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: A retrospective multicenter study. Intensive Care Med. 46:1863–1872. 2020.PubMed/NCBI View Article : Google Scholar

Montrucchio G, Sales G, Rumbolo F, Palmesino F, Fanelli V, Urbino R, Filippini C, Mengozzi G and Brazzi L: Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. PLoS One. 16(e0246771)2021.PubMed/NCBI View Article : Google Scholar

Zhou S, Yang Y, Zhang X, Li Z, Liu X, Hu C, Chen C, Wang D and Peng Z: Clinical course of 195 critically ill COVID-19 patients: A retrospective multicenter study. Shock. 54:644–651. 2020.PubMed/NCBI View Article : Google Scholar

Ouyang SM, Zhu HQ, Xie YN, Zou ZS, Zuo HM, Rao YW, Liu XY, Zhong B and Chen X: Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19. BMC Infect Dis. 20(952)2020.PubMed/NCBI View Article : Google Scholar

Bolondi G, Russo E, Gamberini E, Circell A, Meca MCC, Brogi E, Viola L, Bissoni L, Polett V and Agnoletti V: Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: An observational cohort study. World J Emerg Surg. 15(41)2020.PubMed/NCBI View Article : Google Scholar

Liu X, Shen Y, Wang H, Ge Q, Fei A and Pan S: Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: A prospective observational study. Mediators Inflamm. 2016(8191254)2016.PubMed/NCBI View Article : Google Scholar

Zhang B, Zhou X, Zhu C, Song Y, Feng F, Qiu Y, Feng J, Jia Q, Song Q, Zhu B and Wang J: Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 7(157)2020.PubMed/NCBI View Article : Google Scholar

Garrafa E, Vezzoli M, Ravanelli M, Farina D, Borghesi A, Calza S and Maroldi R: Early prediction of in-hospital death of COVID-19 patients: A machine-learning model based on age, blood analyses, and chest x-ray score. Elife. 10(e70640)2021.PubMed/NCBI View Article : Google Scholar

Liu J, Li SM, Liu J, Liang B, Wang X, Wang H, Li W, Tong O, Yi J, Zhao L, et al: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBiomedicine. 55(102763)2020.PubMed/NCBI View Article : Google Scholar

Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Xu Y, Song R, et al: Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. J Transl Med. 18(206)2020.PubMed/NCBI View Article : Google Scholar

King AH, Mehkri O, Rajendram P, Wang X, Vachharajani V and Duggal A: A high neutrophil-lymphocyte ratio is associated with increased morbidity and mortality in patients with Coronavirus disease 2019. Crit Care Explor. 3(e0444)2021.PubMed/NCBI View Article : Google Scholar

Sarkar S, Khanna P and Singh AK: The impact of neutrophil-lymphocyte count ratio in COVID-19: A systematic review and meta-analysis. J Intensive Care Med. 37:857–869. 2022.PubMed/NCBI View Article : Google Scholar

Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, Luo M, Chen L and Zhao Y: Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infection. 81:e6–e12. 2020.PubMed/NCBI View Article : Google Scholar

Ye W, Chen G, Li X, Lan X, Ji C, Hou M, Zhang D, Zeng G, Wang Y, Xu C, et al: Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res. 21(169)2020.PubMed/NCBI View Article : Google Scholar

Ma A, Cheng J, Yang J, Dong M, Liao X and Kang Y: Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients. Crit Care. 24(288)2020.PubMed/NCBI View Article : Google Scholar

Jiang SQ, Huang QF, Xie WM, Lv C and Quan XQ: The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants. Br J Haematol. 190:e29–e33. 2020.PubMed/NCBI View Article : Google Scholar

Barrett TJ, Bilaloglu S, Cornwell M, Burgess HM, Virginio VM, Drenkova K, Ibrahim H, Yuriditsky E, Aphinyanaphongs Y, Lifshitz M, et al: Platelets contribute to disease severity in COVID-19. J Thromb Haemost. 19:3139–3153. 2021.PubMed/NCBI View Article : Google Scholar

Jiang X, Zhang W, Ma X and Cheng X: Risk of hospital mortality in critically ill patients with transient and persistent thrombocytopenia: A retrospective study. Shock. 58:471–475. 2022.PubMed/NCBI View Article : Google Scholar

Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J, Gao Y, Cai L, Wang Z, Yin P, et al: Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: A retrospective cohort study. Lancet Haematol. 7:e671–e678. 2020.PubMed/NCBI View Article : Google Scholar

Corrêa TD, Cordioli RL, Campos Guerra JC, Caldin da Silva B, dos Reis Rodrigues R, de Souza GM, Midega TD, Campos NS, Carneiro BV, Campos FND, et al: Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study. PLoS One. 15(e0243604)2020.PubMed/NCBI View Article : Google Scholar

British Thoracic Society: BTS Guidance on Venous Thromboembolic Disease in patients with COVID-19. Updated August 2021 - Recently published data and changes to recommendations in red. https://www.brit-thoracic.org.uk/quality-improvement/covid-19/covid-19-information-for-the-respiratory-community/#bts-guidance-on-venous-thromboembolic-disease-in-patients-with-covid-19.

Spadaro S, Fogagnolo A, Campo G, Zucchetti O, Verri M, Ottaviani I, Tunstall T, Grasso S, Scaramuzzo V, Murgolo F, et al: Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients. Crit Care. 25(74)2021.PubMed/NCBI View Article : Google Scholar

Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T and Fritzieri FC: Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis. 50:281–286. 2020.PubMed/NCBI View Article : Google Scholar

Valerio L, Ferrazzi P, Sacco C, Ruf W, Kucher N, Konstantinides SV, Barco S and Lodigiani C: Humanitas COVID-19 Task Force. Course of d-dimer and C-reactive protein levels in survivors and nonsurvivors with COVID-19 pneumonia: A retrospective analysis of 577 patients. Thromb Haemost. 121:98–101. 2021.PubMed/NCBI View Article : Google Scholar

Dujardin RWG, Hilderink BN, Haksteen WE, Middeldorp S, Vlaara APJ, Thachil J, Müller MCA and Juffermans NP: Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients. Thromb Res. 196:308–312. 2020.PubMed/NCBI View Article : Google Scholar

Tang N, Li D, Wang X and Sun Z: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 18:844–847. 2020.PubMed/NCBI View Article : Google Scholar

Juneja GK, Castelo M, Yeh CH, Cerroni SE, Hansen BE, Chessum JE, Abraham J, | Cani E, Dwivedi DJ, Fraser DD, et al: Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 19:1546–1557. 2021.PubMed/NCBI View Article : Google Scholar

Davalos D and Akassoglou K: Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 34:43–62. 2012.PubMed/NCBI View Article : Google Scholar

Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab FB, Creel-Bulos CM and Jabaley CS: Emory COVID-19 Quality & Clinical Research Collaborative. C-reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS One. 15(e0242400)2020.PubMed/NCBI View Article : Google Scholar

Luo X, Zhou W, Yan X, Guo T, Wang B, Xia H, Ye L, Xiong J, Jiang Z, Liu Y, et al: Prognostic value of C-reactive protein in patients with Coronavirus 2019. Clin Infect Dis. 71:2174–2179. 2020.PubMed/NCBI View Article : Google Scholar

Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X and Zhou X: Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 127(104370)2020.PubMed/NCBI View Article : Google Scholar

Oskarsdottir T, Sigurdsson MI, Palsson R and Eythorsson E: Longitudinal changes in inflammatory biomarkers among patients with COVID-19: A nationwide study in Iceland. Acta Anaesthesiol Scand. 66:969–977. 2022.PubMed/NCBI View Article : Google Scholar

Van Oers JAH, Kluiters Y, Bons JAP, de Jongh M, Pouwels S, Ramnarain D, de Lange DW, de Grooth HJ and Girbes ARJ: Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study. J Crit Care. 66:173–180. 2021.PubMed/NCBI View Article : Google Scholar

Wendel-Garcia PD, Moser A, Jeitziner MM, Aguirre-Bermeo H, Arias-Sanchez P, Apolo J, Roche-Campo F, Franch-Llasat D, Kleger GR, Schrag C, et al: Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: An analysis of the prospective, international, multicentre RISC-19-ICU registry. Crit Care. 26(199)2022.PubMed/NCBI View Article : Google Scholar

RECOVERY Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, et al: Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 384:693–704. 2021.PubMed/NCBI View Article : Google Scholar

Chalmers JD, Crichton ML, Goeminne PC, Cao B, Humbert M, Shteinberg M, Antoniou KM, Ulrik CS, Parks H, Wang C, et al: Management of hospitalised adults with coronavirus disease 2019 (COVID-19): A European Respiratory Society living guideline. Eur Resp J. 57(2100048)2021.PubMed/NCBI View Article : Google Scholar

Zacharias H, Mungara R, Wilson AP, Singer M and Arulkumaran N: The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19. J Crit Care. 70(154053)2022.PubMed/NCBI View Article : Google Scholar

Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Lendingham IM and Calman KC: Increased vascular permeability: A major cause of hypoalbuminaemia in disease and injury. Lancet. 1:781–784. 1985.PubMed/NCBI View Article : Google Scholar

Soeters PB, Wolfe RR and Shenkin A: Hypoalbuminemia: Pathogenesis and clinical significance. J Parenter Enteral Nutr. 43:181–193. 2019.PubMed/NCBI View Article : Google Scholar

Siddiqui SS, Chakraborty N, Muzaffar SN and Gurjar M: Albumin kinetics in sepsis and COVID-19. Crit Care Explor. 4(e0651)2022.PubMed/NCBI View Article : Google Scholar

Viana-Lamas MC, Arroyo-Espliguero R, Silva-Obregón JA, Uribe-Heredia G, Núñez-Gil I, García-Magallón B, Torán-Martínez CG, Castillo-Sandoval A, Díaz-Caraballo E, Rodríguez-Guinea I, et al: Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Engl Ed). 156:428–436. 2021.PubMed/NCBI View Article : Google Scholar

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, et al: Clinical characteristics of 113 deceased patients with coronavirus disease. 2019, retrospective study. BMJ. 368(m1091)2020.PubMed/NCBI View Article : Google Scholar

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 130:2620–2629. 2020.PubMed/NCBI View Article : Google Scholar

Su C, Hoffman KL, Xu Z, Sanchez E, Siempos II, Harrington JS, Racanelli AC, Plataki M, Wang F and Schenck EJ: Evaluation of albumin kinetics in critically Ill patients with coronavirus disease 2019 compared to those with sepsis-induced acute respiratory distress syndrome. Crit Care Explor. 3(e0589)2021.PubMed/NCBI View Article : Google Scholar

Venet F, Davin F, Guiqnant C, Larue A, Cazalis MA, Darbon R, Allombert C, Mougin B, Malcus C, Poitevin-Later F, et al: Early assessment of leukocyte alterations at diagnosis of septic shock. Shock. 34:358–363. 2010.PubMed/NCBI View Article : Google Scholar

Monserrat J, de Pablo R, Reyes E, Diaz D, Barcenilla H, Zapata MR, De la Hera A, Prieto A and Alvarez-Mon M: Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care. 13(R26)2009.PubMed/NCBI View Article : Google Scholar

Liu B, Du H, Zhang J, Jiang J, Zhang X, He F and Niu B: Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score) Sci. Rep. 12(20002)2022.PubMed/NCBI View Article : Google Scholar

Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, Fleischmann-Struzek C, Pletz MW, Netea MG, Reinhart K and Kyriazopoulou E: Coronavirus disease 2019 as cause of viral sepsis: A systematic review and meta-analysis. Crit. Care Med. 49:2042–2057. 2021.PubMed/NCBI View Article : Google Scholar

Soriano MC, Vaquero C, Ortiz-Fernandez A, Caballero A, Blandino-Ortiz A and de*Pablo R: Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. J Infect. 82:e20–e21. 2021.PubMed/NCBI View Article : Google Scholar

Kokkoris S, Papachatzakis I, Gavrielatou E, Ntaidou T, Ischaki E, Malachias S, Vrettou C, Nichlos C, Kanavou A, Zervakis D, et al: ICU-acquired bloodstream infections in critically ill patients with COVID-19. J Hosp Infect. 107:95–97. 2021.PubMed/NCBI View Article : Google Scholar

Routsi C, Meletiadis J, Charitidou E, Gkoufa A, Kokkoris S, Karageorgiou S, Giannopoulos C, Koulenti D, Andrikogiannopoulos P, Perivolioti E, et al: Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era. Antibiotics (Basel). 11(771)2022.PubMed/NCBI View Article : Google Scholar

Bhimraj A, Morgan RL, Shumaker AH, Baden L, Cheng VCC, Edwards KM, Gallagher JC, Gandhi RT, Muller WJ, Nakamura MM, et al: Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis: Sep 5, 2022 (Epub ahead of print).

Lyons PG, Micek ST, Hampton N and Kollef M: Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med. 46:736–742. 2018.PubMed/NCBI View Article : Google Scholar